Women who receive COVID-19 mRNA vaccines produced by Pfizer-BioNTech or Moderna while in their third trimester of pregnancy generate a strong immune response and pass protective antibodies through umbilical cord blood to their babies.
Researchers Create Rapid Diagnostic Tests and Multi-Omics Analytics Platforms for SARS-CoV-2 Infection
Two distinct diagnostic tests, a host/pathogen RNA sequencing platform, and spatially-resolved tissue mapping tools were created by a multidisciplinary team of Weill Cornell Medicine and NewYork-Presbyterian Hospital-led researchers and used to map SARS-CoV-2 infections at the height of the initial COVID-19 outbreak in New York City.
NewYork-Presbyterian Brooklyn Methodist Hospital Opens a World-Class Center for Ambulatory Care in Brooklyn: Center for Community Health
Today, NewYork-Presbyterian Brooklyn Methodist Hospital celebrated the opening of the Center for Community Health. The Center for Community Health is a world-class ambulatory care center where leading specialists, working collaboratively under one roof, combine innovative clinical approaches and cutting-edge technology to provide exceptional, comprehensive care to the Brooklyn community.
New COVID-19 Saliva Test Developed by Fertility Experts at Columbia University Irving Medical Center and NewYork-Presbyterian
Researchers at the Columbia University Fertility Center have developed a rapid and accurate one-step diagnostic test that detects SARS-CoV-2, the virus that causes COVID-19, in samples of saliva.